Cargando…

Investigating the role of LSD2 as an epigenetic regulator in Ewing sarcoma

Ewing sarcoma is the second most common solid bone malignancy diagnosed in pediatric and young adolescent populations. Despite aggressive multi-modal treatment strategies, 5-year event-free survival remains at 75% for patients with localized disease and 20% for patients with metastases. Thus, the ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Priyal O., Pishas, Kathleen I., Taslim, Cenny, Selich-Anderson, Julia, Theisen, Emily R., Lessnick, Stephen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570473/ https://www.ncbi.nlm.nih.gov/pubmed/31231465 http://dx.doi.org/10.18632/oncotarget.26988

Ejemplares similares

Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting
por: Theisen, Emily R., et al.
Publicado: (2016)

EWS/FLI mediated reprogramming of 3D chromatin promotes an altered transcriptional state in Ewing sarcoma
por: Showpnil, Iftekhar A, et al.
Publicado: (2022)

Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation
por: Pishas, Kathleen I., et al.
Publicado: (2018)

Chromatin profiling reveals relocalization of lysine-specific demethylase 1 by an oncogenic fusion protein
por: Theisen, Emily R., et al.
Publicado: (2020)

Mitochondrial Dysfunction Is a Driver of SP-2509 Drug Resistance in Ewing Sarcoma
por: Tokarsky, E. John, et al.
Publicado: (2022)

Recent advances in targeted therapy for Ewing sarcoma
por: Pishas, Kathleen I., et al.
Publicado: (2016)

Identification of two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma
por: Johnson, Kirsten M., et al.
Publicado: (2017)

The FLI portion of EWS/FLI contributes a transcriptional regulatory function that is distinct and separable from its DNA-binding function in Ewing sarcoma
por: Boone, Megann A., et al.
Publicado: (2021)

Identification of a Novel FUS/ETV4 Fusion and Comparative Analysis with Other Ewing Sarcoma Fusion Proteins
por: Boone, Megann A., et al.
Publicado: (2021)

Transcriptomic analysis functionally maps the intrinsically disordered domain of EWS/FLI and reveals novel transcriptional dependencies for oncogenesis
por: Theisen, Emily R., et al.
Publicado: (2019)

Network potential identifies therapeutic miRNA cocktails in Ewing sarcoma
por: Weaver, Davis T., et al.
Publicado: (2021)

The ETS transcription factor ETV6 constrains the transcriptional activity of EWS–FLI to promote Ewing sarcoma
por: Lu, Diana Y., et al.
Publicado: (2023)

Targeting the p53 Pathway in Ewing Sarcoma
por: Neilsen, Paul M., et al.
Publicado: (2011)

Cell Cycle Deregulation in Ewing's Sarcoma Pathogenesis
por: Kowalewski, Ashley A., et al.
Publicado: (2011)

Antibody detection of translocations in Ewing sarcoma
por: Luo, Wen, et al.
Publicado: (2012)

Microsatellites with Macro-Influence in Ewing Sarcoma
por: Monument, Michael J., et al.
Publicado: (2012)

BCL11B Is Up-Regulated by EWS/FLI and Contributes to the Transformed Phenotype in Ewing Sarcoma
por: Wiles, Elizabeth T., et al.
Publicado: (2013)

XI-006 induces potent p53-independent apoptosis in Ewing sarcoma
por: Pishas, Kathleen I., et al.
Publicado: (2015)

Is There a Predisposition Gene for Ewing's Sarcoma?
por: Randall, R. L., et al.
Publicado: (2010)

Erratum: XI-006 induces potent p53-independent apoptosis in Ewing sarcoma
por: Pishas, Kathleen I., et al.
Publicado: (2015)

Identifying States of Collateral Sensitivity during the Evolution of Therapeutic Resistance in Ewing's Sarcoma
por: Scarborough, Jessica A., et al.
Publicado: (2020)

Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma
por: Sankar, Savita, et al.
Publicado: (2012)

Targeting Glutathione S-transferase M4 in Ewing sarcoma
por: Zhuo, Rupeng, et al.
Publicado: (2014)

EWS/FLI Mediates Transcriptional Repression via NKX2.2 during Oncogenic Transformation in Ewing's Sarcoma
por: Owen, Leah A., et al.
Publicado: (2008)

Protein phosphatase 1 regulatory subunit 1A regulates cell cycle progression in Ewing sarcoma
por: Luo, Wen, et al.
Publicado: (2020)

Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children’s Oncology Group (COG) New Agents for Ewing Sarcoma Task Force
por: Bailey, Kelly, et al.
Publicado: (2019)

EWS/FLI utilizes NKX2-2 to repress mesenchymal features of Ewing sarcoma
por: Fadul, John, et al.
Publicado: (2015)

Increased risk for other cancers in individuals with Ewing sarcoma and their relatives
por: Abbott, Diana, et al.
Publicado: (2019)

Regulation of Metastasis in Ewing Sarcoma
por: Li, Mingli, et al.
Publicado: (2022)

Epigenetic regulation of LSD1 during mammary carcinogenesis
por: Wu, Yadi, et al.
Publicado: (2014)

Epigenetic control of the EWS-FLI1 promoter in Ewing's sarcoma
por: Montoya, C., et al.
Publicado: (2020)

Targeted Therapy of Ewing's Sarcoma
por: Subbiah, Vivek, et al.
Publicado: (2011)

Biomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children’s Oncology Group
por: Shukla, Neerav, et al.
Publicado: (2013)

Survey of Paediatric Oncologists and Pathologists regarding Their Views and Experiences with Variant Translocations in Ewing and Ewing-Like Sarcoma: A Report of the Children's Oncology Group
por: Kinnaman, Michael D., et al.
Publicado: (2020)

Cutaneous Ewing Sarcoma and Ewing Sarcoma of the Bone: Distinct Diseases
por: Tavakkoli, Montreh, et al.
Publicado: (2018)

Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line
por: Moore, Joseph B., et al.
Publicado: (2015)

Epigenetic and Transcriptional Signaling in Ewing Sarcoma—Disease Etiology and Therapeutic Opportunities
por: Li, Mingli, et al.
Publicado: (2022)

Molecular investigation of Ewing sarcoma: about detecting translocations
por: Blau, Olga
Publicado: (2012)

A Decade in Banking Ewing Sarcoma: A Report from the Children’s Oncology Group
por: Borinstein, Scott C., et al.
Publicado: (2013)

Signature-Based Small Molecule Screening Identifies Cytosine Arabinoside as an EWS/FLI Modulator in Ewing Sarcoma
por: Stegmaier, Kimberly, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_oaocj1sj6lfug479jcvt4rjeo6